Ceapro Inc. (CVE:CZO – Get Free Report) was down 11.8% during trading on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The stock’s 50-day moving average price is C$0.22 and its 200 day moving average price is C$0.23. The firm has a market capitalization of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- Health Care Stocks Explained: Why You Might Want to Invest
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- The How and Why of Investing in Gold Stocks
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
